Source: CTD_human

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
CUI: C0011860
Disease: Diabetes Mellitus, Non-Insulin-Dependent
Diabetes Mellitus, Non-Insulin-Dependent 		0.700 Therapeutic CTD_human Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system. 28182703

2017
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
CUI: C0011860
Disease: Diabetes Mellitus, Non-Insulin-Dependent
Diabetes Mellitus, Non-Insulin-Dependent 		0.700 Biomarker CTD_human Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system. 28182703

2017
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
CUI: C0011860
Disease: Diabetes Mellitus, Non-Insulin-Dependent
Diabetes Mellitus, Non-Insulin-Dependent 		0.700 Therapeutic CTD_human Dual acting and pan-PPAR activators as potential anti-diabetic therapies. 21484566

2011
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
CUI: C0011860
Disease: Diabetes Mellitus, Non-Insulin-Dependent
Diabetes Mellitus, Non-Insulin-Dependent 		0.700 Biomarker CTD_human Dual acting and pan-PPAR activators as potential anti-diabetic therapies. 21484566

2011
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
CUI: C0011860
Disease: Diabetes Mellitus, Non-Insulin-Dependent
Diabetes Mellitus, Non-Insulin-Dependent 		0.700 Biomarker CTD_human Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. 17317762

2007
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
CUI: C0011860
Disease: Diabetes Mellitus, Non-Insulin-Dependent
Diabetes Mellitus, Non-Insulin-Dependent 		0.700 Therapeutic CTD_human Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. 17317762

2007
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
CUI: C0011860
Disease: Diabetes Mellitus, Non-Insulin-Dependent
Diabetes Mellitus, Non-Insulin-Dependent 		0.700 Biomarker CTD_human Our results suggest that PPARG variation may underlie response to TZD therapy in women at risk for type 2 diabetes. 16249460

2005
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
CUI: C0011860
Disease: Diabetes Mellitus, Non-Insulin-Dependent
Diabetes Mellitus, Non-Insulin-Dependent 		0.700 Therapeutic CTD_human Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of beta-cell differentiation and secretory function in the db/db mouse model of diabetes. 16123366

2005
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
CUI: C0011860
Disease: Diabetes Mellitus, Non-Insulin-Dependent
Diabetes Mellitus, Non-Insulin-Dependent 		0.700 Therapeutic CTD_human Our results suggest that PPARG variation may underlie response to TZD therapy in women at risk for type 2 diabetes. 16249460

2005
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
CUI: C0011860
Disease: Diabetes Mellitus, Non-Insulin-Dependent
Diabetes Mellitus, Non-Insulin-Dependent 		0.700 Biomarker CTD_human Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of beta-cell differentiation and secretory function in the db/db mouse model of diabetes. 16123366

2005
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
CUI: C0011860
Disease: Diabetes Mellitus, Non-Insulin-Dependent
Diabetes Mellitus, Non-Insulin-Dependent 		0.700 Biomarker CTD_human Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. 15592662

2004
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
CUI: C0011860
Disease: Diabetes Mellitus, Non-Insulin-Dependent
Diabetes Mellitus, Non-Insulin-Dependent 		0.700 Therapeutic CTD_human Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. 15592662

2004